Henry Wei MD asked an interesting question about a mHealth monitoring opportunity that I’ve been tracking for some time as I can’t wait to be able to help Patients who are managing respiratory conditions with smart mobile connected spirometers with remote coaching and documented 3G Doctor consultations.
I think PNMedical have the vision, passion and product expertise required to follow Alivecor‘s meteoric rise from Dr Albert’s original Fake-as-***** YouTube video in 2010 to being the FDA Cleared trailblazer for the mHealth monitoring market with more than 22 published abstracts & journal articles:
Why not join us at the mHealth group networking meetup on Tuesday at #HIMSS15 and meet with PNMedical‘s CEO & CTO Mark A Carbone.
Who do you think will be the Alivecor of Lung Spirometry?
*** UPDATE 3 April 2017 ***
“Stockholm, Sweden-based Pond Healthcare Innovation, maker of smartphone-connected spirometer Air Smart, has raised $2.1 million (2 million euro) in seed funding from Swedish investment company Spiltan. Using the funding, Pond Healthcare Innovations will build out its team, continue to develop its product, and step up commercialization efforts.
Originally founded in 2014 as a design firm, Pond Healthcare pivoted into medical devices in 2016 after working with Novartis on Air Smart. CEO Lorenzo Consoli came over from Novartis at that point to lead Pond Healthcare.
“While I was at Novartis I worked with Pond Healthcare Innovation to bring to life what today is Air Smart,” Consoli told MobiHealthNews. “It’s a Pond Healthcare Innovation product 100 percent, but I was on the Novartis side to help bring this product to life. Obviously you have the resources of a large company and the agility of a small company and when you put them together it’s pretty powerful.”
Air Smart is a small, portable spirometer with a sleek design. It connects to a smartphone via the audio jack and users can export their data to share with a physician via PDF. Pond Healthcare Innovation offers the product direct to consumers for just 69 euros (about $73), but the company’s strategy is to get physicians to recommend the device to their patients”
“Getting trust from physicians is extremely important,” Consoli said. “Our device is being used by many physicians in Europe and that builds trust. And you know spirometry is not performed very much for many reasons. If you can simplify it, physicians who don’t do spirometry can actually start doing and they discover a lot of things that they weren’t aware of.”